Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Jennifer Doudna
University of Calif Lawrenc Berkeley Lab, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Intellia Therapeutics
Equity Interest - Publicly traded entity (e.g., stock, stock option, or other ownership interest)
Research may benefit company's work of developing therapeutics for sickle cell disease and cystic fibrosis using gene editing.
Electron Microscopy of Biological Macromolecules
Visualizing the structure of biological molecular machines is crucial for a mechanistic understanding of normal cellular function and abnormal disease states that can lead to therapeutic treatment. Cryo-electron microscopy (cryo-EM) is ideally suited for these studies. This Program Project represents a synergistic integration of cryo-EM and biochemical expertise for studies that address fundamental biological questions of great medical significance. It also allows effective sharing of the large costs associated with cryo-EM, while it pushes the capabilities of the cryo-EM technique.
Filed on May 29, 2019.
Tell us what you know about Jennifer Doudna's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Jennifer Doudna”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Jennifer Doudna | University of Calif Lawrenc Berkeley Lab | Conflict of Interest | Intellia Therapeutics | $40,000 - $59,999 |
| Jennifer Doudna | University of Calif Lawrenc Berkeley Lab | Conflict of Interest | Editas Medicine | $100,000 - $149,999 |
| Jennifer Doudna | University of Calif Lawrenc Berkeley Lab | Conflict of Interest | Caribou Biosciences, Inc. | $100,000 - $149,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.